MELAX EXECUTIVE TEAM
Innovative, Collaborative, Professional. Explore for advance clinical data analysis.
MELAX EXECUTIVE TEAM
Hua Xu
CEO
Dr. Xu is the Founder of Melax Technologies Inc. He received his PhD in Biomedical Informatics from Columbia University, and currently is also a part-time professor at The University of Texas Health Science Center at Houston. In the past decade, he has worked on a broad range of challenging NLP topics and clinical NLP methods and systems developed in his lab have been highly recognized. He served as the Chair of AMIA NLP Working Group and currently also leads the NLP Working Group at OHDSI.
Andre Pontin
Chief Business Officer
Andre is an experienced healthcare executive with a proven track record in creating strategic partnerships, scaling startups, large enterprise sales agreements, business development and product innovation. Andre is an integral part of the digital solution landscape and is also an active member in the global digital health ecosystem. He has previously held leadership positions at both 2nd.MD and DoseMe.
Frank Manion
VP for Innovation
Dr. Manion, VP for Innovation, has held executive positions in biomedical informatics support at two major NCI-designated comprehensive cancer centers. He served as Chief Technology Officer and Deputy CIO at the Fox Chase Cancer Center. Until joining Melax he was the Chief Informatics Officer at the Rogel Cancer Center of the University of Michigan. His research interest are the formal semantic representation of biomedical research and clinical data.
Jingqi Wang
Director of Technology
Jingqi Wang serves as the Director of Technology at Melax Technologies Inc, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax. In the past years, he primarily worked on the development and improvement of clinical Natural Language Processing (NLP) algorithms and applications. He has contributed to multiple top-ranked systems in biomedical NLP competitions.
Yaoyun Zhang
Director of NLP Research
Dr. Zhang serves as the Director of NLP Research in Melax. Before joining Melax, she was an Assistant Professor in The University of Texas Health Science Center at Houston. Her primary research interests include natural language processing (NLP), text mining and machine learning. In the past eight years, she has contributed to multiple top ranked systems in biomedical NLP competitions. Her research also contributed to Pharmacovigilance and genetic information extraction from clinical trials.
Richard Wagner
Sales Account Manager
Richard has been a top performing healthcare software sales and management professional with over 25 years’ experience with measurable results. He is experienced in creating market presence and building relationships with both large, billion dollar companies and small start-up companies.